Dose-intensity, dose-escalation, and dose-density in the adjuvant chemotherapy of primary, operable breast cancerNORTON, Larry.Breast disease. 2001, Vol 14, pp 81-89, issn 0888-6008Article

The concept of mathematically optimised dose-scheduling as applied to the adjuvant chemotherapy of primary breast cancer : theory and recent resultsNORTON, Larry.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 2, pp 10-16, issn 1359-6349, 7 p.Conference Paper

Innovative approaches to the treatment of advanced breast cancerNORTON, Larry; PICCART, Martine J.Seminars in oncology. 1997, Vol 24, Num 4, issn 0093-7754, 34 p., SUP10Serial Issue

Patient benefits from new treatment options and schedules for breast cancerSMITH, I. E.Seminars in oncology. 1997, Vol 24, Num 4, pp S10.22-S10.26, issn 0093-7754, SUP10Article

Evolving concepts in the systemic drug therapy of breast cancerNORTON, L.Seminars in oncology. 1997, Vol 24, Num 4, pp S10.3-S10.10, issn 0093-7754, SUP10Article

Docetaxel (Taxotere) for the treatment of anthracycline-resistant breast cancerRAVDIN, P. M.Seminars in oncology. 1997, Vol 24, Num 4, pp S10.18-S10.21, issn 0093-7754, SUP10Article

Translating Mathematical Modeling of Tumor Growth Patterns into Novel Therapeutic Approaches for Breast CancerCOMEN, Elizabeth; MORRIS, Patrick G; NORTON, Larry et al.Journal of mammary gland biology and neoplasia. 2012, Vol 17, Num 3-4, pp 241-249, issn 1083-3021, 9 p.Article

Changing Indications for Surgery in Patients With Stage IV Breast Cancer : A Current PerspectiveMORROGH, Mary; PARK, Anna; NORTON, Larry et al.Cancer. 2008, Vol 112, Num 7, pp 1445-1454, issn 0008-543X, 10 p.Article

Slug Promotes Survival during Metastasis through Suppression of Puma-Mediated ApoptosisSEAHO KIM; JIAHONG YAO; MACIAN, Fernando et al.Cancer research (Chicago, Ill.). 2014, Vol 74, Num 14, pp 3695-3706, issn 0008-5472, 12 p.Article

Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti-CTLA-4 TherapyWAITZ, Rebecca; SOLOMON, Stephen B; PETRE, Elena N et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 2, pp 430-439, issn 0008-5472, 10 p.Article

Frequent Mutational Activation of the PI3K-AKT Pathway in Trastuzumab-Resistant Breast CancerCHANDARLAPATY, Sarat; SAKR, Rita A; KING, Tari A et al.Clinical cancer research (Print). 2012, Vol 18, Num 24, pp 6784-6791, issn 1078-0432, 8 p.Article

HSP90 Inhibition Is Effective in Breast Cancer: A Phase II Trial of Tanespimycin (17-AAG) Plus Trastuzumab in Patients with HER2-Positive Metastatic Breast Cancer Progressing on TrastuzumabMODI, Shanu; STOPECK, Alison; MA, Weining et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5132-5139, issn 1078-0432, 8 p.Article

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)LARA, Jonathan F; THOR, Ann D; CRAIG HENDERSON, I et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5170-5178, issn 1078-0432, 9 p.Article

Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast CancerTRAINA, Tiffany A; RUGO, Hope S; SEIDMAN, Andrew D et al.Journal of clinical oncology. 2010, Vol 28, Num 4, pp 628-633, issn 0732-183X, 6 p.Article

The Safety of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Trastuzumab in HER-2/neu Overexpressed/Amplified Breast CancerDANG, Chau; FORNIER, Monica; GILEWSKI, Theresa et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1216-1222, issn 0732-183X, 7 p.Article

American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerHARRIS, Lyndsay; FRITSCHE, Herbert; MENNEL, Robert et al.Journal of clinical oncology. 2007, Vol 25, Num 33, pp 5287-5312, issn 0732-183X, 26 p.Article

Combination of Trastuzumab and Tanespimycin (17-AAG, KOS-953) Is Safe and Active in Trastuzumab-Refractory HER-2-Overexpressing Breast Cancer : A Phase I Dose-Escalation StudyMODI, Shanu; STOPECK, Alison T; CROPP, Gillian F et al.Journal of clinical oncology. 2007, Vol 25, Num 34, pp 5410-5417, issn 0732-183X, 8 p.Article

Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancerDANG, Chau T; D'ANDREA, Gabriella M; HURRIA, Arti et al.Clinical cancer research. 2004, Vol 10, Num 17, pp 5754-5761, issn 1078-0432, 8 p.Article

Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapyKORNBLITH, Alice B; HERNDON, James E; WINGATE, Patti et al.Cancer. 2003, Vol 98, Num 4, pp 679-689, issn 0008-543X, 11 p.Article

A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinomaSUGARMAN, Steven; WASSERHEIT, Carolyn; GEORGE, Roshini et al.Breast cancer research and treatment. 2009, Vol 115, Num 3, pp 609-612, issn 0167-6806, 4 p.Article

Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerMUSS, Hyman B; BERRY, Donald A; KARTCHESKE, Patricia A et al.The New England journal of medicine. 2009, Vol 360, Num 20, pp 2055-2065, issn 0028-4793, 11 p.Article

Role of Anthracyclines in the Treatment of Early Breast CancerGIANNI, Luca; NORTON, Larry; WOLMARK, Norman et al.Journal of clinical oncology. 2009, Vol 27, Num 28, pp 4798-4808, issn 0732-183X, 11 p.Article

The 6q22.33 Locus and Breast Cancer SusceptibilityKIRCHHOFF, Tomas; CHEN, Zhang-Qun; ROBSON, Mark et al.Cancer epidemiology, biomarkers & prevention. 2009, Vol 18, Num 9, pp 2468-2475, issn 1055-9965, 8 p.Article

SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase : Dependent CancersCHANDARLAPATY, Sarat; SAWAI, Ayana; NORTON, Larry et al.Clinical cancer research. 2008, Vol 14, Num 1, pp 240-248, issn 1078-0432, 9 p.Article

Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National cancer institute of canada clinical trials group MA.17GOSS, Paul E; INGLE, James N; LIVINGSTON, Robert B et al.Journal of clinical oncology. 2007, Vol 25, Num 15, pp 2006-2011, issn 0732-183X, 6 p.Article